Amount Raised
$80 Million
Round Type
Series D
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, today announced the successful completion of an $80 million Series D financing co-led by PFM Health Sciences and Point72. Additional new investors Eventide Asset Management, Surveyor Capital (a Citadel company), Ridgeback Capital Investments, Takeda Ventures Inc., CaaS Capital, JM Family Enterprises, Inc., Northleaf Capital Partners, 404 Bio and an undisclosed investor were joined by existing investors Versant Ventures, OrbiMed, F-Prime Capital, Sectoral Asset Management, Sixty Degree Capital, Brace Pharma Capital and Teralys Capital.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Turnstone Biologics Corp that raised within 45 days of this round, from Fundz verified event records.
- Disc raised $90M (Series B) on September 2, 2021.
- Aarvik Therapeutics raised $8.3M on September 2, 2021.
- PharmaCyte Biotech, Inc. raised $70M on September 1, 2021.
- Os Therapies raised $1M on September 1, 2021.
- Kate Therapeutics raised $35M on August 31, 2021.
- ADARx Pharmaceuticals, Inc. raised $75M on August 17, 2021.
Who to call at Turnstone Biologics Corp, and when
A new round usually means Turnstone Biologics Corp is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Turnstone Biologics Corp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Turnstone Biologics Corp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Turnstone Biologics Corp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Turnstone Biologics Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Turnstone Biologics Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.